发明名称 MODIFIED AMYLOID BETA PEPTIDE
摘要 An object of the invention is to provide a peptide based on a sequence of an amyloid ² peptide that may allow for induction of enhanced immune response and is safe and efficacious for prophylaxis and treatment of Alzheimer disease. An amyloid ² peptide or a portion thereof with addition or insertion of cysteine or a cysteine analogue, and a method for enhancing immune response to amyloid ² using said peptide, a medicament for prophylaxis and treatment of Alzheimer disease using said amyloid peptide that induces an enhanced immune response, amd a DNA vaccine comprising a gene coding for an amyloid ² peptide or a sequence derived from an amyloid ² peptide with addition or insertion of cysteine or a cysteine analogue, as expected to be similarly efficacious.
申请公布号 KR20110071117(A) 申请公布日期 2011.06.28
申请号 KR20117010876 申请日期 2009.10.16
申请人 THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE 发明人 MATSUDA JUNICHI;KAMINAKA KAZUYOSHI;NOZAKI CHIKATERU
分类号 C07K14/435;A61K38/17;A61P25/28;C12N15/12 主分类号 C07K14/435
代理机构 代理人
主权项
地址
您可能感兴趣的专利